Over a year annualised (CAGR), under a year absolute. Computed from AMFI's published
NAV history for this scheme.
Risk
Volatility
Sharpe
Sortino
Beta
Alpha
Max fall
R²
This scheme
16.8%
0.35
0.46
0.71
1.71%
-29.4%
38.71
Nifty 500 benchmark
17.2%
0.35
0.47
—
—
-37.3%
—
Risk-free rate 6.5%. Beta, alpha and R² are regressed on the
83 months this scheme and its benchmark share.
Growth of ₹100 since launch
Drawdown from peak (%)
Every one-year period it has lived through
Windows
Worst
Median
Best
Periods that lost money
355
-20.7%
9.4%
75.6%
35%
Every one-year holding period in this scheme's history, not just the last one — the
spread a real investor would have met depending only on when they started.
How it behaves against its benchmark
Up capture
Down capture
Correlation
Tracking error
Information ratio
Treynor
82%
65%
0.62
16.9%
-0.05
10.92
Up capture is how much of the benchmark's gain this scheme kept in the months the
benchmark rose; down capture, how much of its fall it took. Below 100 on the down side and above it
on the up side is the combination every fund is trying for and few reach.
Measured over the 83 months this scheme and
Nifty 500 share.
ICICI Prudential Healthcare Fund
Regular Plan · IDCW
Allocation
By asset
Equity
97.16%
Cash & Equivalents
2.84%
By market cap
Large Cap
52.52%
Mid Cap
66.35%
Small Cap
74.71%
Unclassified
1.23%
Concentration
Number of stocks
35
Top 5 stocks
39.20%
Top 10 stocks
60.26%
Top 20 stocks
82.13%
Lines in the filing
38
Largest holding
12.69%
Largest sector
Pharmaceuticals & Biotechnology 76.23%
Effective stocks
20.1
Sectors held
6
Cash
2.84%
Effective stocks is what the concentration works out to: a fund holding
35 names but most of its money in a few
behaves like a fund of 20. Cash includes repo and TREPS, which
every fund parks money in overnight.
Sector split
Pharmaceuticals & Biotechnology
76.23%
Healthcare Services
12.22%
Retailing
5.52%
Cash & Equivalents
2.84%
Insurance
1.27%
Chemicals & Petrochemicals
1.18%
Healthcare Equipment & Supplies
0.75%
ICICI Prudential Healthcare Fund
Regular Plan · IDCW · holdings
Top 30 holdings
#
Company
Sector
Shares held
Value ₹ cr
% of fund
1
Sun Pharmaceutical Industries Ltd.
Pharmaceuticals & Biotechnology
4,338,091
864
12.69%
2
Dr. Reddy's Laboratories Ltd.
Pharmaceuticals & Biotechnology
5,008,009
575
8.45%
3
Cipla Ltd.
Pharmaceuticals & Biotechnology
3,027,146
446
6.56%
4
Divi's Laboratories Ltd.
Pharmaceuticals & Biotechnology
509,075
410
6.03%
5
Mankind Pharma Ltd.
Pharmaceuticals & Biotechnology
1,507,093
372
5.47%
6
Alkem Laboratories Ltd.
Pharmaceuticals & Biotechnology
604,704
348
5.11%
7
Biocon Ltd.
Pharmaceuticals & Biotechnology
7,943,167
338
4.97%
8
Cohance Lifesciences Ltd.
Pharmaceuticals & Biotechnology
6,266,692
266
3.92%
9
Medplus Health Services Ltd
Retailing
3,665,005
258
3.80%
10
Syngene International Ltd.
Healthcare Services
5,747,880
222
3.26%
11
MAX Healthcare Institute Ltd
Healthcare Services
1,741,433
191
2.81%
12
Abbott India Ltd.
Pharmaceuticals & Biotechnology
64,361
179
2.63%
13
TREPS
Unclassified
—
175
2.57%
14
Alembic Pharmaceuticals Ltd.
Pharmaceuticals & Biotechnology
2,077,449
166
2.43%
15
Blue Jet Healthcare Ltd.
Pharmaceuticals & Biotechnology
2,597,952
163
2.39%
16
Lupin Ltd.
Pharmaceuticals & Biotechnology
626,941
151
2.23%
17
Pfizer Ltd.
Pharmaceuticals & Biotechnology
277,493
134
1.97%
18
Thyrocare Technologies Ltd.
Healthcare Services
2,286,558
132
1.95%
19
Akums Drugs and Pharmaceuticals Ltd.
Pharmaceuticals & Biotechnology
1,953,248
129
1.89%
20
Astrazeneca Pharma India Ltd.
Pharmaceuticals & Biotechnology
155,814
126
1.86%
21
Entero Healthcare Solutions
Retailing
940,428
117
1.72%
22
Rainbow Childrens Medicare Ltd
Healthcare Services
673,760
103
1.51%
23
Metropolis Healthcare Ltd.
Healthcare Services
1,741,463
101
1.49%
24
Alivus Life Sciences Ltd.
Pharmaceuticals & Biotechnology
779,267
90
1.33%
25
Medi Assist Healthcare Services Ltd
Insurance
2,407,739
86
1.27%
26
Hikal Ltd.
Pharmaceuticals & Biotechnology
3,641,193
81
1.18%
27
Fine Organic Industries Ltd.
Chemicals & Petrochemicals
166,162
80
1.18%
28
Aarti Drugs Ltd.
Pharmaceuticals & Biotechnology
1,865,432
79
1.16%
29
Sanofi Consumer Healthcare India Ltd
Pharmaceuticals & Biotechnology
164,531
76
1.12%
30
Aurobindo Pharma Ltd.
Pharmaceuticals & Biotechnology
350,617
55
0.81%
ICICI Prudential Healthcare Fund
Regular Plan · IDCW · where the money sits
A ₹10,000 monthly SIP over five years
Invested
Value
Gain
XIRR
₹600,000
₹738,038
₹138,038
8.22%
XIRR, not CAGR — a SIP's money arrives over sixty months, so each instalment has
been invested for a different length of time.
Not investment advice. InvestVerdict is not a SEBI-registered Investment Adviser or Research Analyst. Every figure is computed from AMFI's published NAV history and the
portfolio the AMC filed with AMFI; none of it is a recommendation to buy, hold or sell. Past
returns do not predict future ones. Generated 25 Sep 2026.
